Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Lymphoma × repotrectinib × Clear all

Sponsor

Conditions

Thyroid Neoplasms 1 Thyroid Diseases 1 Thoracic Neoplasms 1 Sarcoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Lung Neoplasms 1 Lung Diseases 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Endocrine System Diseases 1 Endocrine Gland Neoplasms 1 Digestive System Neoplasms 1 Colonic Neoplasms 1 Colonic Diseases 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Neuroendocrine 1 Carcinoma, Bronchogenic 1 Carcinoma 1 Bronchial Neoplasms 1 Adenocarcinoma 1

Interventions

Rituximab 4 Lenalidomide 2 Bendamustine Hydrochloride 2 polatuzumab vedotin 1 pirtobrutinib 1 obinutuzumab 1 idelalisib 1 Vincristine 1 Prednisone 1 Fluid Therapy 1 Doxorubicin 1 Cyclophosphamide 1 Crizotinib 1 Brentuximab Vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡